Phenoxymethylpenicillin 250mg tablets

국가: 영국

언어: 영어

출처: MHRA (Medicines & Healthcare Products Regulatory Agency)

유효 성분:

Phenoxymethylpenicillin potassium

제공처:

Waymade Healthcare Plc

ATC 코드:

J01CE02

INN (International Name):

Phenoxymethylpenicillin potassium

복용량:

250mg

약제 형태:

Oral tablet

관리 경로:

Oral

수업:

No Controlled Drug Status

처방전 유형:

Valid as a prescribable product

제품 요약:

BNF: 05010101

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Phenoxymethylpenicillin 250mg Tablets BP
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains Phenoxymethylpenicillin potassium (1515 l-U/mg)
BP
280.00mg
3
PHARMACEUTICAL FORM
White, flat bevelled edge tablets, engraved on one side with company
logo and
with breakline and A057 on the other side
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Phenoxymethylpenicillin and potassium phenoxymethylpenicillin are
indicated in the
treatment of mild to moderately severe infections associated with
micro-organisms
whose susceptibility to penicillin is within the range of serum levels
attained with
these dosage forms. The following infections will usually respond to
adequate doses:
Streptococcal infections (without bacteraemia): Mild to moderate
infections of the
upper respiratory tract, scarlet fever and mild erysipelas.
Pneumococcal infections: Mild to moderately severe infections of the
respiratory
tract.
Staphylococcal infections sensitive to penicillin: Mild infections of
the skin and soft
tissues.
Fusospirochaetosis (Vincent’s gingivitis and pharyngitis): Mild to
moderately severe
infections of the oropharynx usually respond to therapy with oral
penicillin.
Prophylactic use: Prophylaxis with oral penicillin has proved
effective in preventing
reccurrence of rheumatic fever and chorea.
Patients with a past history of rheumatic fever receiving continuous
prophylaxis may
harbour penicillin-resistant organisms. In these patients, the use of
another
prophylactic agent should be considered.
Note: severe empyema, bacteraemia, pericarditis, meningitis and
arthritis should not
be treated with Phenoxymethylpenicillin during the acute phase.
Consideration should be given to official guidance on the appropriate
use of
antibacterial agent.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults:
125-500mg
every
4-6
hours
depending
on
the
severity
of
the
condition.
Prophylactic
use:
125mg
twice
daily
is
recommended
for
long
term
prophylaxis of rheumatic fever